- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05555693
Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain Metabolomic Characteristics in Elderly Patients
September 26, 2022 updated by: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Postoperative cognitive dysfunction (POCD) refers to the difficulties of orientation, cognition, communication, memory and abstract thinking of patients after anesthesia and surgery.
And/or accompanied by the decline of the ability in social activities, such as the change of personality, social ability of language and behavior, cognitive function and life skills.
POCD is a common complication of central nervous system in elderly patients after operation, with an early incidence of about 21% and a long-term incidence of about 35% .
According to the current research on Alzheimer's disease (AD) and POCD in the elderly, it has been found that they have similar pathological basis and some homologous related genes.
Altogether, POCD is closely related to molecular pathway neuropsychiatric diseases (such as dementia, depression and Alzheimer's disease).
Researchers have come up with various hypotheses to reveal the underlying mechanisms of POCD, including neuritis, oxidative stress, autophagy disorder, synaptic dysfunction, and lack of neurotrophic support.
To date, apart from evaluating with scales, CT Scan and EEG analysis, there is neither exact biomarkers for monitoring and diagnosing POCD, nor clear relationships between specific Brain Metabolomic Characteristics, EEG changes and diagnosis of POCD, so that the diagnosis of early POCD only stays in the evaluation of clinical symptoms and scales.
Therefore, our study aims to provide an effective basis for early diagnosis and treatment of clinical POCD through multivariate analyses of clinical scales combined with Brain Metabolomic Characteristics, EEG analysis of patients.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ren Zhou, PhD
- Phone Number: 15121007303
- Email: zhouren77@126.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200000
- Recruiting
- Shanghai 9Th Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Our research is a single center, nested case-control study.
Preoperatively collect the information of the elderly patients over 65 years old without undergoing craniocerebral operations, including the vital signs, the examination reports and other related data after excluding the factors that can't be included in the group.
The patients' health scales and preoperative cognitive function scales were evaluated.
Description
Inclusion Criteria:
- 65 years or older .
- Complete the operation in our hospital
- ASA classification I-II level
- Agree to participate in this research and agree to sign an informed consent form
Exclusion Criteria:
- History of preoperative psychosis and psychotropic drug use
- The subject is diagnosed with AD;
- Abnormal preoperative mental scale assessment
- Have a history of emergency rescue during the perioperative period
- metal implants
- Postoperative immobilization patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients in the control group were followed up without POCD postoperatively.
If the MOCA or MMSE assessment all show a negative resluts at all time point.
|
Collecting clinical data(before induction of anesthesia and first day after surgery), EGG(first day after surgery),Magnetic Resonance Spectroscopy data (before induction of anesthesia and first day after surgery)blood gas data(before induction of anesthesia and first day after surgery) and blood sample (before induction of anesthesia and first day, third day and 7th day after surgery)
|
Patients in the case group were followed up with POCD postoperatively.
If the MOCA assessment is positive at any time point after surgery, and there is a positive MMSE at any time point after surgery(no need for both MOCA and MMSE to be positive at the same time
|
Collecting clinical data(before induction of anesthesia and first day after surgery), EGG(first day after surgery),Magnetic Resonance Spectroscopy data (before induction of anesthesia and first day after surgery)blood gas data(before induction of anesthesia and first day after surgery) and blood sample (before induction of anesthesia and first day, third day and 7th day after surgery)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MMSE (mini-mental state examiniation)
Time Frame: 1 day after surgery
|
MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
1 day after surgery
|
MMSE (mini-mental state examiniation)
Time Frame: immediately before surgery
|
MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
immediately before surgery
|
MMSE (mini-mental state examiniation)
Time Frame: 3 day after surgery
|
MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
3 day after surgery
|
MMSE (mini-mental state examiniation)
Time Frame: 7 day after surgery
|
MMSE scale score, If the MMSE assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
7 day after surgery
|
MOCA (Montreal Cognitive Assessment)
Time Frame: 1 day after surgery
|
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
1 day after surgery
|
MOCA (Montreal Cognitive Assessment)
Time Frame: 3 day after surgery
|
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
3 day after surgery
|
MOCA (Montreal Cognitive Assessment)
Time Frame: 7 day after surgery
|
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
7 day after surgery
|
MOCA (Montreal Cognitive Assessment)
Time Frame: immediately before surgery
|
MOCA sacle score, If the MOCA assessment is positive at any time point, and there is a positive MMSE at any time point (no need for both MOCA and MMSE to be positive at the same time), it is defined as the occurrence of POCD.
|
immediately before surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3D-CAM
Time Frame: 1 day after surgery
|
3D-CAM score
|
1 day after surgery
|
Self-Rating Anxiety Scale
Time Frame: immediately before surgery
|
Self-Rating Anxiety Scale score
|
immediately before surgery
|
Self-rating depression scale
Time Frame: immediately before surgery
|
Self-rating depression scale score
|
immediately before surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 27, 2022
Primary Completion (Anticipated)
January 1, 2027
Study Completion (Anticipated)
December 1, 2027
Study Registration Dates
First Submitted
September 22, 2022
First Submitted That Met QC Criteria
September 26, 2022
First Posted (Actual)
September 27, 2022
Study Record Updates
Last Update Posted (Actual)
September 27, 2022
Last Update Submitted That Met QC Criteria
September 26, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SH9H-2022-T133-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on POCD - Postoperative Cognitive Dysfunction
-
Mu Dong LiangNot yet recruitingPostoperative Cognitive Dysfunction(POCD)
-
TC Erciyes UniversityNot yet recruitingPOCD - Postoperative Cognitive Dysfunction | Mechanical Bowel Preparation
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedPostoperative Cognitive Dysfunction | POCDUnited States
-
dengji wangUnknown
-
Charite University, Berlin, GermanyActive, not recruitingNeurocognitive Disorders | Postoperative Cognitive Deficit (POCD)Germany
-
Tanta UniversityMagrabi Hospital - DohaCompleted
-
Gangnam Severance HospitalRecruitingAnemia | Transfusion | POCDKorea, Republic of
-
Beni-Suef UniversityActive, not recruiting
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedPostoperative Delirium | Postoperative Cognitive Dysfunction | PD | POCDUnited States
-
Charite University, Berlin, GermanyEuropean UnionTerminatedPostoperative Delirium (POD) | Postoperative Cognitive Deficit (POCD)Germany, Netherlands
Clinical Trials on Collecting clinical data, EGG,Brain Metabolomic Characteristics(with Magnetic Resonance Spectroscopy), blood gas data and blood sample
-
Shanghai Ninth People's Hospital Affiliated to...Recruiting
-
Shanghai Ninth People's Hospital Affiliated to...Active, not recruitingDelayed Neurocognitive RecoveryChina
-
University Hospital, Basel, SwitzerlandBotnar Research Centre for Child HealthCompleted
-
Rigshospitalet, DenmarkCompletedChronic Kidney Diseases | Type2 Diabetes | Non-Alcoholic Fatty Liver DiseaseDenmark
-
University Hospital, BordeauxUniversity of Bordeaux; Centre National de la Recherche Scientifique, France; Labex BrainRecruiting
-
Uniformed Services University of the Health SciencesWalter Reed National Military Medical CenterTerminatedTraumatic Brain InjuryUnited States
-
National Cancer Institute (NCI)RecruitingStage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam